Novel vesicular system: An overview

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 1, 2012, Pages 193-202

  Jadhav, Seema M ^a   Morey, Pournima ^a   Karpe, Mrs Manisha ^a   Kadam, Vilasrao ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Applications; Controlled drug delivery; Stability; Vesicular system

Indexed keywords

EID: 84872238693     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Akiladevi D., Basak S. Ethosomes - a Noninvasive approach for transdermal drug delivery Int. J. Cur. Pharma. Res. 2010; Vol. 2 (4):1-4.
2. Allen TM, Ahmed I, Lopes de Menezes DE. Immunoliposome mediated targeting of anti cancer drugs in vivo. Biochem. Soc. Trans.1995; 23:1073.
3. Baille A.J., Florence A.T., Hume L. R., Muirhead G. T., Rogerson A.J. The effect of cholesterol on single chain, non-ionic surfactant vesicles. J. Pharm. Pharmacol. (suppl.). 1984; 36: 48.
4. Baille A.J., Florence A.T., Hume L. R., Muihead G., Rogerson A. J. The preparation and properties of niosomes-nonionic surfactant vesicles. J. Pharm. Pharmacol. 1985; 37: 863.
5. Bangham A.D., Standish M.M., Watkins J.G. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965; 13:238.
6. Biju S.S., Talegaonkar S., Mishra P.R., Khar R.K. Vesicular systems: An overview. Ind. J. Pharma. Sci. 2006; Vol. 68 (2):141-153.
7. Brewer J.M., Alexander J.A. The adjuvant activity of non-ionic surfactant vehicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology. 1992; 75 (4): 570-575.
8. Cevc G., Blume G., Schatzlein A. Transferosomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Release. 1997; 45:211.
9. Cevc G. Transferosomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Sysm. 1996; 13(3-4): 257-388.
10. Cevc G., Schatzlein A., Blume G. Transdermal drug carriers: Basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides. J. Control. Release. 1995; 36: 3-16.
11. Dayan N., Touitou E. Carrier for skin delivery of trihexyphenidyl HCl: Ethosomes vs liposomes, Biomaterials. 2002; 21: 1879-1885.
12. Dkeidek I., Touitou E. Ethosomes: a recent approach in transdermal/topical delivery. AAPS Pharm. Sci, 1999; 1: 202.
13. Dubey V., Mishra D., Dutta T., Nahar M., Saraf D.K., Jain N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control. Release. 2007; 123: 148-154.
14. Ehab R., Bendas L., Mina I., Tadros. Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes. AAPS Pharm. Sci. Tech. 2007; 8 (4): 213-220.
15. Fry D.W., White J.C., Goldman I.D. Rapid secretion of low molecular weight solutes from liposomes without dilution. Anal. Biochem, 1978; 90:809-815.
16. Goldberg E.P.Eds., In; Targeted Drugs, 2nd edn, Wiley, Newyork, (1983) 312.
17. Guo J., Ping Q., Sun G., Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int. J. Pharm. 2000; 194(2):201-207.
18. Horwitz E., Pisanty S., Czerninsky R., Helser M., Eliav E., Touitou E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatments of recurrent herpes labialis, Oral Surg Oral Pathol Oral Radiol Endod. 1999; 88:700-05.
19. Jain NK. Controlled and novel drug delivery. 1st ed. CBS publishers and distributors. New Delhi (2001).
20. Jain NK. Advances in Controlled and Novel Drug Delivery. CBS Publishers, New Delhi, India (2003) 273-278.
21. Jain S., Jain P. Transferosomes: A novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation, Drug Dev. Ind. Pharm. 2003; 29: 1013-1026.
22. Jain S., Jaio N., Bhadra D., Tiwari A.k., Jain N.K. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Current Drug Delivery. 2005; 2(3): 223-33.
23. Jain S., Mishra D., Kuksal A., Tiwary A. K., Jain N. K. Vesicular approach for drug delivery into or across the skin: current status and future prospects, www.Pharmainfo.net.
24. Jayaraman C.S., Ramachandran C., Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J. Pharm. Sci. 1996; 85 (10): 1082-1084.
25. Kirpotin D.B., Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes Amsterdam: Elsevier; 1998; 325.
26. Lawrence M. J. Surfactant Systems: Their Use in Drug Delivery. Chem. Soc. Rev. 1994; 23: 417-424.
27. Lodzki M., Godin B., Rakou L., Mechoulam R., Gallily R., Touitou E. Cannabidiol- transdermal delivery and anti-inflammatory effects in a murine model. J. Control. Release. 2003; 93:27: 377-387.
28. Maghraby G.M.M., Williams A.C., Barry B.W. Oestradiol skin delivery from ultra deformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 2000; 196: 63-74.
29. Malhotra M., Jain N.K. Niosomes as Drug Carriers, Indian Drugs. 1994; 31 (3): 81-86.
30. Mayer L. D., Cullis P. R., Bally M. B., In; Lasic D. D., Papahadjopoulos, D., Eds. Applications of Liposomes. Elsevier, Amsterdam. 1998; 231.
31. Paolino D., Lucania G., Mardente D., Alhaique F., Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Release. 2005; 106: 99-110.
32. Patel H.M., Stevenson R.W., Parons J.A., Ryman B.E. Use of liposomes. Biochem. Biophys. Acta 1982; 716: 188-193.
33. Patel S. Ethosomes: A promising tool for transdermal delivery of drug, Pharma Info.Net. 2007; 5(3).
34. Paul A., Cevc G., Bachhawat B.K. Transdermal immunization with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transferosomes, Vaccine. 1998; 16 (2-3): 188-195.
35. Poste G., Krisch R., Koestler T. Liposome Technology. Vol. 3, CRC Press Inc, Banco Raton, F1. 1983; 29.
36. Rogerson A., Cummings J., Willmott N., Florence A. T. J. Pharm. Pharmacol.1988; 40: 337.
37. Saraf S., Paliwal S., Saraf S. Sphingosomes a novel appoach to vesicular drug delivery. Int. J. Cur. Sci. Res. 2011; 1(2): 63-68.
38. Schatzlein A., Cevc G. In; Cevc G., Paltauf E. Eds., Phospholipids characterization, metabolism, and novel biological applications, AOCS press, Champaign 1995; 191.
39. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., Blume U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 2004; 123:168-176.
40. Touitou E., inventor. Composition of applying active substance to or through the skin. US patent 5 540 934. July 30, 1996.
41. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release. 2000; 65: 403-418.
42. Touitou E., Godin B., Dayan N., Vaisman B. Intracellular delivery by cationic ethosomes not containing positively charged phospholipids: Characterization and intracellular delivery properties. Proceedings of the 6th PAT & 4th ICRS International Symposium, Eilat, Israel. 2001.
43. Touitou E., Godin B., Dayan N., Weiss C. Intracellular Delivery Mediated By An Ethosomal Carrier. Biomaterials. 2001; 22: 3053-3059.
44. Touitou E., inventor. Composition of applying active substance to or through the skin. US patent 5 716 638. October 2, 1998.
45. Vaizoglu O., Speiser P.P. Pharmacosomes: an emerging vesicular system. Acta Pharm Suec. 1986; 23:163.
46. Vanden Berge BAI, Swartzendruber VAB, Geest J. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J. Microsc.1997; 187(2): 125-133.
47. Vyas SP and Khar RK. Targeted and controlled drug delivery. 1st ed. CBS publisher. New Delhi (2002).
48. Webb M.S., Bally M.B., Mayor L.D. Inex Pharmaceutical Corporation. Sphingosome for enhanced drug delivery.US Patent 5543152. 1996; June 8.
49. Yoshioka T., Sternberg B., Florence A. T. Preparation and properties of vesicles (niosomes) of sobitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 1994; 105: 1-6.
50. Zhang Z.R., Wang J.X., J. Lu Optimization of the Preparation of 3', 5'-dioctanoyl-5-fluoro-2'-deoxyuridine Pharmacosomes Using Central Composite Design. Yao Xue Xue Bao 2001; 36 (6): 456-461.